Skip to main content
Equibles
OM logo

OM · Outset Medical, Inc. · Short Interest

Track OM — free

Use OM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.14 -0.01 (-0.32%)
Rebalance outlook locked
Market Cap
$59.21M
Shares
18.80M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

OM Latest Reported Short Interest

FINRA reported 901,682 OM shares sold short as of the August 31, 2026 settlement date, a decrease of 34,659 shares. Days to cover was 6.99 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

OM Short Interest Forecast

Equibles' model estimates 940,350 shares sold short for the September 15, 2026 settlement, +4.3% versus the latest reported position, with a likely range of 838,252 to 1,068,463 shares. This model prediction uses FINRA data through September 15, 2026; FINRA's official release is expected September 24, 2026.

Model estimate

Expected Sep 15 short interest

as of Sep 15 High confidence 69% chance it rises
940,350 +4.3% vs reported
Likely range 838,252 to 1,068,463 The latest estimate appears in the chart below. Official release expected Sep 24. Methodology
Short Squeeze Score
53/100
Short interest 4.8% of shares — P71 Days to cover 7.0 — P77 Price vs VWAP -28.9% — P8 Short-volume trend +0.1% — P49 Short interest change -3.7% — P31 Worst FTD 0.01% of shares — P44

Positioning score 52.9 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-31). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-09-15 22:18 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-30 Scheduled
    FINRA publishes Oct 9
    		 — — — —
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 901,682 936,341 -34,659 6.99
    2026-08-14 936,341 1,142,402 -206,061 5.97
    2026-07-31 1,142,402 1,216,685 -74,283 11.02
    2026-07-15 1,216,685 1,493,147 -276,462 6.28
    2026-06-30 1,493,147 1,970,839 -477,692 3.27
    2026-06-15 1,970,839 2,223,191 -252,352 10.61
    2026-05-29 2,223,191 2,054,656 +168,535 13.21
    2026-05-15 2,054,656 2,010,092 +44,564 9.54
    2026-04-30 2,010,092 2,088,243 -78,151 15.43
    2026-04-15 2,088,243 1,945,946 +142,297 20.12
    2026-03-31 1,945,946 2,094,187 -148,241 13.28
    2026-03-13 2,094,187 1,915,455 +178,732 7.98
    2026-02-27 1,915,455 2,217,364 -301,909 7.73
    2026-02-13 2,217,364 2,267,637 -50,273 6.33
    2026-01-30 2,267,637 2,293,147 -25,510 5.47
    2026-01-15 2,293,147 2,326,008 -32,861 1.00
    2025-12-31 2,326,008 2,221,361 +104,647 4.81
    2025-12-15 2,221,361 2,118,659 +102,702 4.33
    2025-11-28 2,118,659 2,096,697 +21,962 3.41
    2025-11-14 2,096,697 1,728,691 +368,006 2.14
    2025-10-31 1,728,691 1,946,640 -217,949 6.50
    2025-10-15 1,946,640 1,724,184 +222,456 6.21
    2025-09-30 1,724,184 1,851,950 -127,766 11.82
    2025-09-15 1,851,950 1,950,146 -98,196 13.97

    Full FINRA short interest reporting calendar

    Showing 1–24 of 24 settlements
    Key facts CIK 1484612 CUSIP 690145206 13F (30d) 5 filings 5 filers Visit website Investor relations